Also Known As:
Oncomine MDS Panel - MyeloDysplastic Syndrome
It is a next-generation sequencing test designed to identify genetic mutations associated with myelodysplastic syndromes (MDS). This genetic analysis helps your doctor understand your condition and plan personalised care.
Includes 1 Test Parameters
Test Preparation:
No Special Preparation. Informed Consent Required.
Reporting TAT:
24 Hours